Home Infusion Therapy Market Size By Product (Infusion Pump, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

Published Date: May 2020  |  Report ID: GMI435  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 130   |   Base Year: 2019




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Home Infusion Therapy Market size exceeded USD 21 billion in 2019 and is anticipated grow a CAGR of 11% between 2020 and 2026. The market growth is attributed to the cost efficiency and improved patient outcomes, along with rise in chronic diseases such as cancer, diabetes, asthma, obesity, and other life-threatening conditions. These medical conditions will impel the market expansion over the forecast period. Additionally, the adoption of home infusion therapy products and services in developed and underdeveloped regions has increased due to cost-effective treatments in the past few years, thereby fostering the market value positively.
 

Home Infusion Therapy Market Overview

Get more details on this report - Request Free Sample PDF
 

High preference of homecare facilities coupled with the rise in geriatric population will boost the acceptance of home infusion therapy products and services globally

Rising preference for homecare facilities is poised to have positive impact on the demand for home infusion therapy services and products. Growing need to reduce the inpatient duration stays in hospitals is expected to propel the industry growth. For instance, as per the American Hospital Association, in 2018, approximately 36 million hospital admissions were registered in the U.S. This has enforced to develop the strategies for the administration of home infusion therapy at homecare facilities and assisted in the industry expansion.
 

Furthermore, immunocompromised patients, paediatrics and rising geriatric population coupled with various chronic diseases such as hospital-acquired infections and diabetes will further drive the industry value. Key market players are further focusing on the development of home infusion therapy devices by utilizing advanced technologies. However, risk associated with irregular functioning of infusion devices coupled with dearth of reimbursement policies for home infusion therapy may hamper the market progression over the forecast period.
 

Increasing usage of insulin pumps for rapid action will supplement the home infusion therapy market revenue

Home Infusion Therapy Market Share

Get more details on this report - Request Free Sample PDF
 

Infusion pump segment was valued at around USD 10.7 billion in 2019. These pumps are extensively used in medical settings such as homecare, hospitals and nursing homes and thus significantly contribute to the medical devices market. In addition, infusion pumps offer several advantages including delivery of fluids at automated intervals or précised programmed rates and ability to deliver fluids in tiny volumes.
 

Rising demand for anti-infective therapy will create profitable opportunities

Anti-infective segment is slated to expand at 10.8% growth rate through 2026 led by the administration of medication such as anti-fungal and antibiotics that are performed in large number of procedures. This will generate significant demand for anti-infective therapy thereby, fuelling the industry progression. The advantage of anti-infective treatment with home infusion therapy will led to cost-effective treatment by reducing in-patients stays in hospitals and exposure to the hospital-acquired infections.
 

Presence of major industry player in North America region will stimulate the market demand

Home Infusion Therapy Market Size

Get more details on this report - Request Free Sample PDF
 

U.S. dominated the North America home infusion therapy market and accounted for over USD 8.4 billion in 2019. One of the key factors responsible for the industry growth across the U.S. is the presence of major market players in the North America region. Increasing prevalence of chronic diseases will serve as a major impact rendering factor for the North America market size. Factors such as treatment cost, product launches and technological advancements are predicted to upsurge the regional growth. Such factors will help in development of healthcare facilities, thereby augmenting the home infusion therapy product demand. Moreover, growing shift towards the preference from acute care to homecare settings due to enhanced patient mobility and cost-effective treatment will accelerate the market progression in the coming years.
 

Implementation of various strategies is estimated to create competitive advantages in the market growth

Some of the eminent companies operating in the market include B. Braun Melsungen, Baxter, Fresenius Kabi, Becton, Dickinson & Company, Eli Lilly & Company, Smiths Medical, Terumo Corporation and ICU Medical, among others. These major industry participants are focusing on various strategies such as R&D for new product launch, mergers & acquisitions to sustain the industry expansion.
 

Recent industry developments:

  • In April 2020, B Braun Melsungen received Emergency Use Authorization (EUA) from U.S. FDA for the use of infusion pump with nebulizers to treat COVID-19 patients. This has resulted in increased sales, expansion of customer base.
     
  • In October 2018, Baxter International Inc. collaborated with the American Society for enteral and parenteral nutrition. The collaboration has led to launch of SmartPN tool that assist in reducing clinical malnutrition. This has increased the demand and further assisted in the industry progression.
     

The market research report on home infusion therapy includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:

Market, By Product

  • Infusion Pump
  • Intravenous Sets
  • IV Cannulas
  • Needleless Connectors

Market, By Application

  • Anti-infective
  • Hydration Therapy
  • Chemotherapy
  • Enteral Nutrition
  • Parenteral Nutrition
  • Specialty Pharmaceuticals
  • Other

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea 
  • Latin America
    • Mexico
    • Brazil
  • Middle East & Africa
    • South Africa

 

Frequently Asked Questions (FAQ) :

The market size of home infusion therapy exceeded USD 21 billion in 2019.
The industry share of home infusion therapy is projected to grow at 11% through 2026.
U.S. dominated the North America market and was valued at around USD 8.4 billion in 2019.
Anti-infective segment is expected to expand at a CAGR of 10.8% through 2026.
Key companies operating in the market include B. Braun Melsungen, Baxter, Fresenius Kabi, Becton, Dickinson & Company, Eli Lilly & Company, Smiths Medical, Terumo Corporation and ICU Medical, among others.

Premium Report Details

  • Published Date: May 2020
  • Pages: 130
  • Tables: 122
  • Charts / Figures: 14
  • Companies covered: 10
  • Countries covered: 15

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X